{"id":63065,"title":"Is rituximab one for all ages and each sex?","abstract":"In this issue of Blood, Pfreundschuh et al report that young males treated with rituximab-based immunochemotherapy in contrast to elderly males benefit as much as females from rituximab immunochemotherapy and patients with more rapid rituximab clearance have reduced therapeutic benefit.","date":"2014-01-31","categories":"Hemic and Lymphatic Diseases","split":"test","url":"http://www.ncbi.nlm.nih.gov/pubmed/24482494","annotations":[{"name":"Blood","weight":0.654997,"wikipedia_article":"http://en.wikipedia.org/wiki/Blood"},{"name":"Old age","weight":0.114132,"wikipedia_article":"http://en.wikipedia.org/wiki/Old_age"},{"name":"Rituximab","weight":0.0297972,"wikipedia_article":"http://en.wikipedia.org/wiki/Rituximab"},{"name":"Copyright","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Copyright"},{"name":"Therapy","weight":0.0159005,"wikipedia_article":"http://en.wikipedia.org/wiki/Therapy"},{"name":"Therapeutic effect","weight":0.0152478,"wikipedia_article":"http://en.wikipedia.org/wiki/Therapeutic_effect"},{"name":"Sex","weight":0.0147415,"wikipedia_article":"http://en.wikipedia.org/wiki/Sex"}]}
